Clinical Trial Update: RA Denosumab on Bone Microstructure Study [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating denosumab's effect on bone microstructure in rheumatoid arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Denosumab (denosumab)

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Rheumatoid Arthritis | Phase 4 | Status: COMPLETED